✨ Free AI Report
Precision BioSciences, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Precision BioSciences, Inc.
Research Preview

Precision BioSciences, Inc.: Business Overview, Financials & Competitive Analysis

Precision BioSciences is a clinical-stage biotechnology company developing the ARCUS® genome editing platform. ARCUS is designed with therapeutic safety, delivery, and control in mind, targeting high unmet need diseas...

Analyst-debate audio for Precision BioSciences, Inc.

AskCyborg analysts argue the bull and bear cases for Precision BioSciences, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Precision BioSciences, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Gene editing platform with transformative potential in hepatitis B and DMD, trading at attractive valuation with clear 2026 data...

Read the full analyst-debate transcript →
Industry Biotechnology - Gene Editing & Gene Therapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Precision BioSciences, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Precision BioSciences, Inc. Overview

Pro stress-test →

Precision BioSciences is a clinical-stage biotechnology company developing the ARCUS® genome editing platform. ARCUS is designed with therapeutic safety, delivery, and control in mind, targeting high unmet need diseases including hepatitis B and Duchenne muscular dystrophy.

Strategic Profile

Pro stress-test →

The company's ARCUS platform differs from other technologies in the way it cuts, its smaller size, and simpler structure, with capabilities enabling more intended, defined therapeutic outcomes. With $137M in cash as of December 31, 2025, the company is positioned to fund key data milestones through 2028, focusing on clinical validation of two lead programs in 2026.

Competitive Landscape

Pro stress-test →

PBGENE-DMD utilizes a gene excision approach differentiated from existing microdystrophin and exon skipping treatments. Precision competes with other gene editing platforms and DMD therapeutics developers, but its in vivo ARCUS platform and potential for curative therapies positions it uniquely in the genome editing space.

Industry Context

Precision BioSciences, Inc. operates in Biotechnology - Gene Editing & Gene Therapy.

Key facts

Headquarters: Durham, North Carolina

What the analysts stress-tested

The top findings that survived the multi-agent debate for Precision BioSciences, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Precision BioSciences, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Exon-skipping therapiesExisting DMD treatment modality→Microdystrophin gene therapyAlternative DMD approach→Gene editing platformsCompeting genome editing technologies→

Compare Precision BioSciences, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Precision BioSciences, Inc. operates in Biotechnology - Gene Editing & Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Gene Editing & Gene Therapy research →
NEW · MCP server

Ask your AI assistant about Precision BioSciences, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Precision BioSciences, Inc. and its top competitor on Cyborg Score”
“What did Precision BioSciences, Inc. do this quarter?”
“Is Precision BioSciences, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Precision BioSciences, Inc. do?+
Precision BioSciences is a clinical-stage biotechnology company developing the ARCUS® genome editing platform. ARCUS is designed with therapeutic safety, delivery, and control in mind, targeting high unmet need diseas...
What is Precision BioSciences, Inc.'s Cyborg Score?+
Precision BioSciences, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Precision BioSciences, Inc.'s main competitors?+
Named competitors include Exon-skipping therapies, Microdystrophin gene therapy, Gene editing platforms. The full competitive landscape is in the AskCyborg report.
How can I get the full Precision BioSciences, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Precision BioSciences, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Precision BioSciences, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9National Bank of Pakistan9RENK Group AG9Lumentum Holdings Inc.9First Abu Dhabi Bank9The Travelers Companies, Inc.9BAE Systems plc9Arista Networks9KLA Corporation9Hermès International S.A.8Enerjisa Enerji A.Ş.8Emirates Central Cooling Systems Corporation8WALLIX Group8StealthGas Inc.8SofWave Medical Ltd.8Himalaya Shipping Ltd.8Bannerman Energy Ltd8Sembcorp Salalah Power & Water Company8MilDef Group